DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET

被引：0
|
作者：
Werner, Jan-Michael [1 ,2 ]
Ceccon, Garry [1 ,2 ]
Weller, Johannes [3 ]
Schaub, Christina [3 ]
Tscherpel, Caroline [1 ,2 ]
Lohmann, Philipp [4 ]
Bauer, Elena [1 ,2 ]
Schaefer, Niklas [3 ]
Stoffels, Gabriele [4 ]
Kabbasch, Christoph [2 ,5 ]
Baues, Christian [2 ,6 ]
Marnitz, Simone [2 ,6 ]
Fink, Gereon R. [1 ,2 ]
Langen, Karl-Josef [4 ]
Herrlinger, Ulrich [3 ]
Galldiks, Norbert [1 ,2 ]
机构：
[1] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Univ Hosp Bonn, Dept Neurol, Div Clin Neurooncol, Bonn, Germany
[4] Res Ctr Juelich, Inst Neurosci & Med, Julich, Germany
[5] Univ Cologne, Fac Med, Dept Neuroradiol, Cologne, Germany
[6] Univ Cologne, Fac Med, Dept Radiat Oncol, Cologne, Germany
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NIMG-26
引用
收藏
页码：152 / 153
页数：3
相关论文
共 50 条
  • [21] DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET
    Galldiks, Norbert
    Dunkl, Veronika
    Stoffels, Gabriele
    Hutterer, Markus
    Rapp, Marion
    Kebir, Sied
    Goldbrunner, Roland
    Ruge, Maximilian I.
    Schmidt, Matthias
    Langen, Karl-Josef
    NEURO-ONCOLOGY, 2014, 16
  • [22] DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET
    Galldiks, N.
    Dunkl, V.
    Stoffels, G.
    Hutterer, M.
    Rapp, M.
    Kebir, S.
    Goldbrunner, R.
    Ruge, M. I.
    Schmidt, M.
    Langen, K.
    NEURO-ONCOLOGY, 2014, 16
  • [23] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
    Chinot, O. L.
    Rouge, T. de la Motte
    Moore, N.
    Zeaiter, A.
    Das, A.
    Phillips, H.
    Modrusan, Z.
    Cloughesy, T.
    ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
  • [24] DUAL FET PET-GUIDED SIB IN RADIOTHERAPY OF NEWLY DIAGNOSED GLIOBLASTOMA - A PILOT STUDY
    Harat, Maciej
    Blok, Maciej
    Wiatrowska, Izabela
    Furtak, Jacek
    Malkowski, Bogdan
    NEURO-ONCOLOGY, 2021, 23 : 45 - 45
  • [25] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
    O. L. Chinot
    T. de La Motte Rouge
    N. Moore
    A. Zeaiter
    A. Das
    H. Phillips
    Z. Modrusan
    T. Cloughesy
    Advances in Therapy, 2011, 28 : 334 - 340
  • [26] A network meta-analysis of treatment for newly diagnosed glioblastoma based on radiotherapy plus temozolomide
    Zheng, Mao-hua
    Sun, Hong-tao
    Xu, Ji-guang
    Zhang, Yong-hong
    Yang, Gang
    Huo, Lei-ming
    Tian, Jin-hui
    Yang, Ke-hu
    Zheng, Mao-hua
    Sun, Hong-tao
    NEUROLOGY ASIA, 2017, 22 (01) : 49 - 58
  • [27] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, Lazaros
    Schaefer, Niklas
    Kebir, Sied
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Glas, Martin
    NEURO-ONCOLOGY, 2018, 20 : 119 - 120
  • [28] Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis
    Erpolat, Ozge Petek
    Akmansu, Muge
    Goksel, Fatih
    Bora, Huseyin
    Yaman, Emel
    Buyukberber, Suleyman
    TUMORI JOURNAL, 2009, 95 (02): : 191 - 197
  • [29] Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
    Herrlinger, Ulrich
    Tzaridis, Theophilos
    Mack, Frederic
    Steinbach, Joachim Peter
    Schlegel, Uwe
    Sabel, Michael
    Hau, Peter
    Kortmann, Rolf-Dieter
    Krex, Dietmar
    Grauer, Oliver
    Goldbrunner, Roland
    Schnell, Oliver
    Baehr, Oliver
    Uhl, Martin
    Seidel, Clemens
    Tabatabai, Ghazaleh
    Kowalski, Thomas
    Ringel, Florian
    Schmidt-Graf, Friederike
    Suchorska, Bogdana
    Brehmer, Stefanie
    Weyerbrock, Astrid
    Renovanz, Miriam
    Bullinger, Lars
    Galldiks, Norbert
    Vajkoczy, Peter
    Misch, Martin
    Vatter, Hartmut
    Stuplich, Moritz
    Schaefer, Niklas
    Kebir, Sied
    Weller, Johannes
    Schaub, Christina
    Stummer, Walter
    Tonn, Joerg-Christian
    Simon, Matthias
    Keil, Vera C.
    Nelles, Michael
    Urbach, Horst
    Coenen, Martin
    Wick, Wolfgang
    Weller, Michael
    Fimmers, Rolf
    Schmid, Matthias
    Hattingen, Elke
    Pietsch, Torsten
    Coch, Christoph
    Glas, Martin
    LANCET, 2019, 393 (10172): : 678 - 688
  • [30] Combination of Tumor Treating Fields (TTFields) with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Lazaridis, L.
    Kebir, S.
    Weller, J.
    Tzaridis, T. -D
    Scheffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Schaefer, N.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S109 - S109
12345